Skip to content
Annalist
Companies Atlas Screener Compare Deal Lab For AI agents Data Quality Method

Vertex Pharmaceuticals Incorporated

VRTX · Nasdaq · Health care, biotechnology · United States · US GAAP · Fiscal year ends December

Latest report: Q3 FY2026, the quarter ended 30 September 2026, released 3 November 2026. Snapshot FY2026Q3_3e58470d.

Overview

Revenue, quarter
+11.8% year on year
Operating income, quarter
−39.9% year on year
Net income, quarter
−39.6% year on year
Diluted EPS, quarter
−39.0% year on year
Operating margin, last 4 quarters
−0.8pp year on year
Return on equity, last 4 quarters
−1.5pp year on year

Select a figure to see the document it came from.

Key Findings

Findings for the latest quarter, with their history over earlier quarters.

  1. Revenue for the quarter ended 30 September 2026 was US$3.4 billion, 11.8% higher than in the same quarter a year earlier.

    Confirmedin Q3 FY2026 · stated since Q3 FY202411.8% from 12.5% in Q2 FY2026
    Rule: Revenue against a year earlier · Sources 10-Q 2026-09
    History of this finding, 9 records
    1. Q3 FY2026 ConfirmedRevenue for the quarter ended 30 September 2026 was US$3.4 billion, 11.8% higher than in the same quarter a year earlier.Recorded from FY2026Q3_3e58470d · data update
    2. Q2 FY2026 StrengthenedRevenue for the quarter ended 30 June 2026 was US$3.3 billion, 12.5% higher than in the same quarter a year earlier.Reconstructed · data update
    3. Q1 FY2026 WeakenedRevenue for the quarter ended 31 March 2026 was US$3.0 billion, 7.8% higher than in the same quarter a year earlier.Reconstructed · data update
    4. Q4 FY2025 WeakenedRevenue for the quarter ended 31 December 2025 was US$3.2 billion, 9.5% higher than in the same quarter a year earlier.Reconstructed · data update
    5. Q3 FY2025 WeakenedRevenue for the quarter ended 30 September 2025 was US$3.1 billion, 11.0% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q2 FY2025 StrengthenedRevenue for the quarter ended 30 June 2025 was US$3.0 billion, 12.1% higher than in the same quarter a year earlier.Reconstructed · data update
    7. Q1 FY2025 WeakenedRevenue for the quarter ended 31 March 2025 was US$2.8 billion, 3.0% higher than in the same quarter a year earlier.Reconstructed · data update
    8. Q4 FY2024 StrengthenedRevenue for the quarter ended 31 December 2024 was US$2.9 billion, 15.7% higher than in the same quarter a year earlier.Reconstructed · data update
    9. Q3 FY2024 NewRevenue for the quarter ended 30 September 2024 was US$2.8 billion, 11.6% higher than in the same quarter a year earlier.Reconstructed · initial
  2. Net income attributable to the company was US$654 million, 39.6% lower than in the same quarter a year earlier.

    Newin Q3 FY2026 · first stated
    Rule: Net income against a year earlier · Sources 10-Q 2026-09
    History of this finding, 13 records
    1. Q3 FY2026 NewNet income attributable to the company was US$654 million, 39.6% lower than in the same quarter a year earlier.Recorded from FY2026Q3_3e58470d · data update
    2. Q3 FY2026 RetiredThe finding changed to lower than a year earlier.Recorded from FY2026Q3_3e58470d · data update
    3. Q2 FY2026 WeakenedNet income attributable to the company was US$1.1 billion, 6.5% higher than in the same quarter a year earlier.Reconstructed · data update
    4. Q1 FY2026 StrengthenedNet income attributable to the company was US$1.0 billion, 59.6% higher than in the same quarter a year earlier.Reconstructed · data update
    5. Q4 FY2025 StrengthenedNet income attributable to the company was US$1.2 billion, 30.5% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q3 FY2025 NewNet income attributable to the company was US$1.1 billion, 3.6% higher than in the same quarter a year earlier.Reconstructed · data update
    7. Q3 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    8. Q2 FY2025 NewNet income attributable to the company was US$1.0 billion, against a net loss of US$3.6 billion in the same quarter a year earlier.Reconstructed · data update
    9. Q2 FY2025 RetiredThe finding changed to a profit after a loss a year earlier.Reconstructed · data update
    10. Q1 FY2025 StrengthenedNet income attributable to the company was US$646 million, 41.2% lower than in the same quarter a year earlier.Reconstructed · data update
    11. Q4 FY2024 NewNet income attributable to the company was US$913 million, 5.8% lower than in the same quarter a year earlier.Reconstructed · data update
    12. Q4 FY2024 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    13. Q3 FY2024 NewNet income attributable to the company was US$1.0 billion, 1.0% higher than in the same quarter a year earlier.Reconstructed · initial
  3. The operating margin over the last 4 quarters was 33.2%, 0.8 percentage points lower than a year earlier.

    Newin Q3 FY2026 · first stated
    Rule: Operating margin against a year earlier · Sources 10-K 2025-12, 10-Q 2025-09, 10-Q 2026-03 and 2 more
    History of this finding, 11 records
    1. Q3 FY2026 NewThe operating margin over the last 4 quarters was 33.2%, 0.8 percentage points lower than a year earlier.Recorded from FY2026Q3_3e58470d · data update
    2. Q3 FY2026 RetiredThe finding changed to lower than a year earlier.Recorded from FY2026Q3_3e58470d · data update
    3. Q2 FY2026 WeakenedThe operating margin over the last 4 quarters was 38.0%, 3.6 percentage points higher than a year earlier.Reconstructed · data update
    4. Q1 FY2026 StrengthenedThe operating margin over the last 4 quarters was 38.3%, 45.0 percentage points higher than a year earlier.Reconstructed · data update
    5. Q4 FY2025 StrengthenedThe operating margin over the last 4 quarters was 34.8%, 36.9 percentage points higher than a year earlier.Reconstructed · data update
    6. Q3 FY2025 WeakenedThe operating margin over the last 4 quarters was 34.1%, 36.6 percentage points higher than a year earlier.Reconstructed · data update
    7. Q2 FY2025 NewThe operating margin over the last 4 quarters was 34.4%, 37.7 percentage points higher than a year earlier.Reconstructed · data update
    8. Q2 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    9. Q1 FY2025 StrengthenedThe operating margin over the last 4 quarters was -6.7%, 47.9 percentage points lower than a year earlier.Reconstructed · data update
    10. Q4 FY2024 WeakenedThe operating margin over the last 4 quarters was -2.1%, 40.9 percentage points lower than a year earlier.Reconstructed · data update
    11. Q3 FY2024 NewThe operating margin over the last 4 quarters was -2.5%, 42.7 percentage points lower than a year earlier.Reconstructed · initial
  4. Return on equity over the last 4 quarters was 20.8%, against 22.3% a year earlier.

    Newin Q3 FY2026 · first stated
    Rule: Return on equity against a year earlier · Sources 10-Q 2025-09, 10-Q 2026-09, 10-K 2025-12 and 3 more
    History of this finding, 11 records
    1. Q3 FY2026 NewReturn on equity over the last 4 quarters was 20.8%, against 22.3% a year earlier.Recorded from FY2026Q3_3e58470d · data update
    2. Q3 FY2026 RetiredThe finding changed to lower than a year earlier.Recorded from FY2026Q3_3e58470d · data update
    3. Q2 FY2026 WeakenedReturn on equity over the last 4 quarters was 23.5%, against 22.8% a year earlier.Reconstructed · data update
    4. Q1 FY2026 StrengthenedReturn on equity over the last 4 quarters was 24.2%, against -5.6% a year earlier.Reconstructed · data update
    5. Q4 FY2025 ConfirmedReturn on equity over the last 4 quarters was 22.5%, against -3.2% a year earlier.Reconstructed · data update
    6. Q3 FY2025 WeakenedReturn on equity over the last 4 quarters was 22.3%, against -3.0% a year earlier.Reconstructed · data update
    7. Q2 FY2025 NewReturn on equity over the last 4 quarters was 22.8%, against -3.2% a year earlier.Reconstructed · data update
    8. Q2 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    9. Q1 FY2025 StrengthenedReturn on equity over the last 4 quarters was -5.6%, against 24.4% a year earlier.Reconstructed · data update
    10. Q4 FY2024 ConfirmedReturn on equity over the last 4 quarters was -3.2%, against 23.0% a year earlier.Reconstructed · data update
    11. Q3 FY2024 NewReturn on equity over the last 4 quarters was -3.0%, against 23.5% a year earlier.Reconstructed · initial
  5. Free cash flow over the last 4 quarters was US$3.2 billion, and operating cash flow was 0.9 times net income attributable to the company.

    Interpretation. Operating cash flow paid for all capital expenditure, and the rest is free for dividends, share buybacks or debt repayment.

    Weakenedin Q3 FY2026 · stated since Q2 FY2025
    Rule: Free cash flow · Sources 10-K 2025-12, 10-Q 2025-09, 10-Q 2026-03 and 2 more
    History of this finding, 10 records
    1. Q3 FY2026 WeakenedFree cash flow over the last 4 quarters was US$3.2 billion, and operating cash flow was 0.9 times net income attributable to the company.Recorded from FY2026Q3_3e58470d · data update
    2. Q2 FY2026 ConfirmedFree cash flow over the last 4 quarters was US$3.8 billion, and operating cash flow was 1.0 times net income attributable to the company.Reconstructed · data update
    3. Q1 FY2026 StrengthenedFree cash flow over the last 4 quarters was US$3.7 billion, and operating cash flow was 1.0 times net income attributable to the company.Reconstructed · data update
    4. Q4 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$3.2 billion, and operating cash flow was 0.9 times net income attributable to the company.Reconstructed · data update
    5. Q3 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$3.3 billion, and operating cash flow was 1.0 times net income attributable to the company.Reconstructed · data update
    6. Q2 FY2025 NewFree cash flow over the last 4 quarters was US$3.5 billion, and operating cash flow was 1.1 times net income attributable to the company.Reconstructed · data update
    7. Q2 FY2025 RetiredThe finding changed to positive.Reconstructed · data update
    8. Q1 FY2025 StrengthenedOperating cash flow over the last 4 quarters was an outflow of US$980 million, and free cash flow after purchases of property, plant and equipment an outflow of US$1.3 billion.Reconstructed · data update
    9. Q4 FY2024 WeakenedOperating cash flow over the last 4 quarters was an outflow of US$493 million, and free cash flow after purchases of property, plant and equipment an outflow of US$790 million.Reconstructed · data update
    10. Q3 FY2024 NewOperating cash flow over the last 4 quarters was an outflow of US$843 million, and free cash flow after purchases of property, plant and equipment an outflow of US$1.1 billion.Reconstructed · initial
  6. Cash and short-term investments exceeded total debt by US$1.8 billion at 30 September 2026.

    Newin Q3 FY2026 · first stated
    Rule: Net debt or net cash · Sources 10-Q 2026-09
    History of this finding, 3 records
    1. Q3 FY2026 NewCash and short-term investments exceeded total debt by US$1.8 billion at 30 September 2026.Recorded from FY2026Q3_3e58470d · data update
    2. Q1 FY2026 RetiredThe rule did not apply to the figures as at Q1 FY2026.Reconstructed · data update
    3. Q4 FY2025 NewCash and short-term investments exceeded total debt by US$6.6 billion at 31 December 2025.Reconstructed · initial

Records before Q3 FY2026 are reconstructed from the latest snapshot. Ledger: findings.json.

Credit, liquidity, earnings quality and score findings: Analysis.

Data

Source documents27 documents, latest Form 10-Q, period ended 30 September 2026List
SnapshotFY2026Q3_3e58470d

Corporate Events

No corporate event found in the filings since 2020.

Earnings, Returns and Balance Sheet

Revenue

By quarter, US dollars

Operating Income

By quarter, US dollars

Net Income Attributable to the Company

By quarter, US dollars

Margins

Last 4 quarters at each quarter end, per cent

Returns

Last 4 quarters, per cent

Free Cash Flow

Operating cash flow less capital expenditure, by quarter, US dollars

Net Debt

Total debt less cash and short-term investments, at quarter end, US dollars

Diluted Earnings per Share

By quarter, as reported

Financial Statements

Figures as filed. Select a figure for its source document and method; a small d marks a quarter derived from cumulative reports.

The statements are loading. They are also available as JSON and CSV.

Ratios

Select a ratio for its formula and the figures it uses, each with its document; (i) gives its definition.

The ratios are loading.

Source Documents

Documents of this snapshot, latest first.

DocumentDateId
Form 10-Q, period ended 30 September 20263 Nov 202610-Q:0000875320-26-000291
Form 10-Q, period ended 30 June 20264 Aug 202610-Q:0000875320-26-000259
Form 10-Q, period ended 31 March 20265 May 202610-Q:0000875320-26-000173
Form 10-K, period ended 31 December 202513 Feb 202610-K:0000875320-26-000056
Form 10-Q, period ended 30 September 20254 Nov 202510-Q:0000875320-25-000232
Form 10-Q, period ended 30 June 20255 Aug 202510-Q:0000875320-25-000216
Form 10-Q, period ended 31 March 20256 May 202510-Q:0000875320-25-000192
Form 10-K, period ended 31 December 202413 Feb 202510-K:0000875320-25-000053
Form 10-Q, period ended 30 September 20245 Nov 202410-Q:0000875320-24-000223
Form 10-Q, period ended 30 June 20242 Aug 202410-Q:0000875320-24-000198
Form 10-Q, period ended 31 March 20247 May 202410-Q:0000875320-24-000139
Form 10-K, period ended 31 December 202315 Feb 202410-K:0000875320-24-000062
Form 10-Q, period ended 30 September 20237 Nov 202310-Q:0000875320-23-000031
Form 10-Q, period ended 30 June 20232 Aug 202310-Q:0000875320-23-000021
Form 10-Q, period ended 31 March 20232 May 202310-Q:0000875320-23-000012
Form 10-K, period ended 31 December 202210 Feb 202310-K:0000875320-23-000007
Form 10-Q, period ended 30 September 202228 Oct 202210-Q:0000875320-22-000038
Form 10-Q, period ended 30 June 20225 Aug 202210-Q:0000875320-22-000030
Form 10-Q, period ended 31 March 20226 May 202210-Q:0000875320-22-000014
Form 10-K, period ended 31 December 20219 Feb 202210-K:0000875320-22-000007
Form 10-Q, period ended 30 September 20213 Nov 202110-Q:0000875320-21-000033
Form 10-Q, period ended 30 June 202130 Jul 202110-Q:0000875320-21-000027
Form 10-Q, period ended 31 March 202130 Apr 202110-Q:0000875320-21-000015
Form 10-K, period ended 31 December 202011 Feb 202110-K:0000875320-21-000006
Form 10-Q, period ended 30 September 202030 Oct 202010-Q:0000875320-20-000043
Form 10-Q, period ended 30 June 202031 Jul 202010-Q:0000875320-20-000030
Form 10-Q, period ended 31 March 20201 May 202010-Q:0000875320-20-000019

Checks

262257 of 262 checks passed, 5 warnings
Fiscal calendar70 passedFiscal years last 350 to 380 days, quarters 80 to 125 days, and each period starts on the day after the one before. Checked at error level.
Quarters and fiscal year119 passedThe 4 quarters of every item add up to its fiscal year, or a later filing restated the year. Checked at error level.
Withheld values1 value withheldA value that contradicts the definition of its item, or that documents report in contradiction, is withheld. Checked at warning level.
Operating lease cost, Q4 FY2024: withheld, negative where the item cannot be negative
Filer identity1 passedThe documents are those of the company of this page. Checked at error level.
Balance sheet identity27 passedTotal assets equal total liabilities and equity at each balance sheet date. Checked at error level.
Balance sheet structure4 passedTotal assets equal liabilities, temporary equity and total equity. Checked at warning level.
Lease liabilities3 of 7 passedLease payments due, less imputed interest, equal the lease liabilities. Checked at warning level.
31 Dec 2020: $397m against $361m
30 Sep 2024: $1,861m against $1,655m
31 Dec 2024: $1,831m against $1,632m
31 Dec 2025: $2,145m against $1,924m
Quarters and 9 months21 passedThe 3 reported quarters of a fiscal year add up to the reported 9-month figure. Checked at error level.
Earnings per share6 passedNet income divided by average shares agrees with reported basic earnings per share. Checked at warning level.
Primary statements6 passedEach key figure of the latest fiscal year is a line of the income statement, the balance sheet or the cash flow statement of the annual report. Checked at warning level.

Data Quality

How many values of this snapshot the checks prove, and how many Annalist derives, withholds and tracks as restated. Every company.

Values published1,340
Confirmed by other figures49.7%, 666 values
Confirmed by a second document0.0%, 0 values
Derived from reported figures20.2%, 271 values
Values withheld1
Restated figures tracked117
Changes compared on one basis14
Company lines mapped0 of 0 reviewed

Citation

Annalist, Vertex Pharmaceuticals Incorporated, snapshot vertex-pharmaceuticals/FY2026Q3_3e58470d (as of FY2026 Q3); <item label>, <period>; source <document id> (<document url>)

Snapshot FY2026Q3_3e58470d · dataset SHA-256 3e58470d5c2b9d172f2fbd1573019a46fd9fce41bbc3a706e670cf03f1edffbf · findings rules 0.5

Data: info.json · dataset.json · validation.json · documents.json